Prothena Corporation plc provided earnings guidance for the year 2024. The company expects full year 2024 net cash used in operating and investing activities to be between $208 million and $225 million. The estimated full year 2024 net cash used in operating and investing activities is primarily driven by an estimated net loss of $229 million to $255 million, which includes an estimated $51 million of noncash share-based compensation expense.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.04 USD | -7.18% | -14.88% | -45.21% |
May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.21% | 1.16B | |
+10.68% | 115B | |
+11.63% | 106B | |
-6.31% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.19% | 17.56B | |
-40.50% | 17.32B | |
+6.30% | 14.03B | |
+31.75% | 12.13B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Corporation plc Provides Earnings Guidance for the Year 2024